Œ€‹†¬‰Κ

1)Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients withosteoporosis: Japanese Osteoporosis Intervention Trial-03

Tanaka S, Miyazaki T, Uemura Y, Miyakawa N, Gorai I, Nakamura T,Fukunaga

M, Ohashi Y, Ohta H, Mori S, Hagino H, Hosoi T, Sugimoto T, Itoi E, Orimo

H, Shiraki M.

J Bone Miner Metab Publish online:02 August 2016.DOI 10.1007/s00774-016-0768-5

2)Comparison of expert and nonexpert physicians in the assessment of vertebral fractures using the semiquantitative method in Japan.

Uemura Y,Miyakawa N, Orimo H, Shiraki M, Nakamura T, Mori S.

J Bone Miner Metab33: 642-650, 2015.

3) Impact of Osteonecrosis of the Jaw on Osteoporosis Treatment in Japan: Results of a Questionnaire-Based Survey by the Adequate Treatment of Osteoporosis (A-TOP) Research@Group.

Taguchi A, Shiraki M, Tsukiyama M, Miyazaki T, Soen S, Ohta H, Nakamura T, Orimo H.

Calcif Tissue Int 97:542-550, 2015.@Published online 26 July 2015.

4) Serum 25 hydroxyvitamin D level as an independent determinant of quality

of life in osteoporosis with high risk for fracture.

Ohta H, Uemura Y, Nakamura T, Fukunaga M, Ohashi Z, Hosoi T, Mori S, Sugimoto T, Itoi E, Orimo H, Shiraki M for the Adequate Treatment of Osteoporosis.(A-TOP)research group.

Clin Therap. 36: 225-235, 2014.

5) Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03).

Tanaka S, Miyazaki T, Uemura Y, Kuroda T, Miyakawa N, Nakamura T, Fukunaga M, Ohashi Y, Ohta H, Mori S, Hagino H, Hosoi T, Sugimoto T, Itoi E, Orimo H, Shiraki M.

J Bone Miner Metab. 32: 298-304, 2014.

6) Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT)- 02.

Orimo H, Nakamura T, Fukunaga M, Ohta H, Hosoi T, Uemura Y, Kuroda T, Miyakawa N, Ohashi Y, Shiraki M; A-TOP (Adequate Treatment of Osteoporosis)research group.

Curr Med Res Opin. 2011 Jun;27(6):1273-84

7) Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures: rationale, aims and organization of a Japanese Osteoporosis Intervention Trial(JOINT) initiated by the Research Group of Adequate Treatment of Osteoporosis (A-TOP).

Shiraki M, Kuroda T, Hosoi T, Ohashi Y, Ohta H, Fukunaga M, Nakamura T, Orimo H et al.

J Bone Miner Metab. 2011 Jan;29(1):37-43.